Form 8-K - Current report:
SEC Accession No. 0001193125-25-250823
Filing Date
2025-10-27
Accepted
2025-10-27 09:08:33
Documents
10
Period of Report
2025-10-23
Items
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K neog-20251023.htm   iXBRL 8-K 83758
  Complete submission text file 0001193125-25-250823.txt   190860

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT neog-20251023.xsd EX-101.SCH 25023
12 EXTRACTED XBRL INSTANCE DOCUMENT neog-20251023_htm.xml XML 4730
Mailing Address 620 LESHER PLACE LANSING MI 48912
Business Address 620 LESHER PLACE LANSING MI 48912 5173729200
NEOGEN CORP (Filer) CIK: 0000711377 (see all company filings)

EIN.: 382367843 | State of Incorp.: MI | Fiscal Year End: 0531
Type: 8-K | Act: 34 | File No.: 000-17988 | Film No.: 251417684
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)